Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
CollPlant Biotechnologies Ltd.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security
Type |
Security
Class Title |
Fee
Calculation Rule |
Amount
Registered |
(1) | Proposed Maximum Offering Price Per Share |
Maximum Aggregate Offering Price |
Fee Rate | Amount
of Registration Fee |
||||||||||||||||
| Equity | Ordinary shares, par value NIS 1.50 per share (2) | 457(c); 457(h) | 600,000 | $ | 5.89 | $ | 3,534,000.00 | $ | 0.0001476 | $ | 521.62 | |||||||||||||
| Total Offering Amount | 600,000 | $ | 3,534,000.00 | $ | 521.62 | |||||||||||||||||||
| Total Fees Previously Paid | — | |||||||||||||||||||||||
| Total Fee Offsets | — | |||||||||||||||||||||||
| Net Fee Due | $ | 521.62 | ||||||||||||||||||||||
| (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended, this registration statement shall also cover any additional ordinary shares that become issuable under the CollPlant Biotechnologies Ltd. 2024 Share Award Plan (the “Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction. |
| (2) | Represents ordinary shares issuable upon vesting of awards granted under the Plan as well as future award grants under the Plan and the corresponding proposed maximum offering price per share, which is estimated solely for purposes of calculating the filing fee pursuant to Rule 457 (c) and (h), the aggregate offering price and the fee have been computed upon the basis of the average of the high and low prices per share of the registrant’s ordinary shares as reported on the Nasdaq Global Market on May 28, 2024. |